- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02074969
Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures
Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures - Epidemiological Data and Rates of Complications
Study Overview
Detailed Description
This trial is a prospective randomized controlled study including the treatment of AO/OTA 31-A2 fractures in 200 patients with 2 different surgical devices. 100 patients are treated with a Gamma Nail 3 (GN3) (Stryker) the other 100 patients with a Proximal Femoral Nail Antirotation (PFNA) (Synthes).
All surgeries are performed by trauma surgeons at a Level 1 University Hospital. One hundred patients are randomized to the gamma nail and 100 are randomized to the proximal femoral nail for treatment fixation. A 1:1 randomization is performed using sealed envelopes (200 in total), which are opened by the surgeon immediately before the operation.
Patients missing an informed consent form, incomplete chart, or showing a pathologic fracture are getting excluded from final comparisons.
Patients anthropometric data as well as pre-injury mobility assessments, and ASA will be documented. Furthermore the time from admission to going to surgery, surgery length, length of stay and mobility assessment at dischargement are recorded.
After surgery the stay in the hospital is documented precisely and patients are scheduled for next appointments 2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.
Postoperative X-rays are measured precisely to determine the Tip-Apex Distance (TAD), the Parkers-Ratio, the Singh-Score and the Neck-Shaft-Angle of the injured and contralateral side. Rates of complications as cut-out and reoperation-rates are evaluated. All intra-operative complications are noted and included in the chart.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Department of Trauma, Medical University of Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- AO/OTA 31-A2 fractures
- age between 18 - 100 years
- Signed written informed consent and agreement to attend the planned FUs
- Able to understand and read country national language at an elementary level
Exclusion Criteria:
- missing informed consent form
- pathological fracture
- incomplete patient record
- death within one month of intervention (surgery)
- prior surgery to the hip
- polytrauma
- any additional fracture
- any implant at the same hip
- infection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Gamma Nail 3
Gamma Nail 3 Stryker.
|
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.
Other Names:
|
Active Comparator: PFNA
PFNA Antirotation Synthes
|
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
re-operation rate
Time Frame: time between intervention and one year after
|
time between intervention and one year after
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Screw-Cut Out
Time Frame: time between intervention and one year after
|
evaluation of sliding movements of the hip screw in the sense of a cut-out
|
time between intervention and one year after
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mobility assessment
Time Frame: time between hospitalization and one year after intervention
|
Mobility assessment includes scoring of pre-operative level of mobility and mobility after intervention
|
time between hospitalization and one year after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Harald K. Widhalm, M.D., Department of Trauma, Medical University of Vienna, Austria
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007406
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fractures
-
University Hospital, GhentCompletedWounds and Injuries | Ankle Fractures | Wrist Fractures | Elbow Fractures | Forearm Fractures | Foot FracturesBelgium
-
Oslo University HospitalUniversity of Oslo; University Hospital of North Norway; Norwegian University... and other collaboratorsCompletedHip Fractures | Ankle Fractures | Osteoporotic Fractures | Humeral Fractures, Proximal | Vertebral Compression Fractures | Wrist FracturesNorway
-
University of Kansas Medical CenterNot yet recruitingFemoral Neck Fractures | Distal Radius Fractures | Femoral Shaft Fracture | Intertrochanteric Fractures | Patella Fracture | Lisfranc Injuries | Distal Femur Fracture | Calcaneus Fractures | Clavicle Fractures | Proximal Humerus Fractures | Tibial Shaft Fracture With or Without Associated Fibula Fracture | Ankle... and other conditionsUnited States
-
Herlev and Gentofte HospitalRecruitingIntra-Articular Fractures | Distal Humerus Fracture | Comminuted FractureDenmark
-
AO Clinical Investigation and Publishing DocumentationCompletedReverse Oblique Intertrochanteric Fractures | Reverse Oblique Subtrochanteric FracturesAustralia, Switzerland
-
AO Innovation Translation CenterRecruitingHip Fractures | Tibial Fractures | Distal Radius Fracture | Ankle Fractures | Humeral Fracture, ProximalUnited States, Colombia, Germany, Austria, United Kingdom
-
Peking University Third HospitalBeijing Yanqing HospitalRecruitingFemoral Intertrochanteric FracturesChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedFracturesFrance, Germany, Canada, United States, Australia, Mexico, Brazil, Finland, Norway, Romania, Sweden
-
AO Clinical Investigation and Publishing DocumentationSynthes Inc.CompletedUnstable Trochanteric FracturesSpain
-
AO Clinical Investigation and Publishing DocumentationSynthes Inc.CompletedHumerus Fracture | Femur Fracture | Tibia FractureAustria, Germany
Clinical Trials on Gamma Nail 3
-
Wolfson Medical CenterUnknownIntertrochanteric Femoral FracturesIsrael
-
Florida Orthopaedic InstituteUnknownHip Fracture | Intertrochanteric FractureUnited States
-
Puerta de Hierro University HospitalNot yet recruitingProximal Femoral FracturesSpain
-
University Hospital, GhentCompletedPertrochanteric and Subtrochanteric Femur FracturesBelgium
-
Medical University of ViennaCompleted
-
Instituto Traumatologico Dr. Teodoro Gebauer WeisserUnknown
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
AO Clinical Investigation and Publishing DocumentationSynthes Inc.CompletedUnstable Trochanteric FracturesSpain
-
Assiut UniversityUnknownTrochanteric Fractures
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker OsteosynthesisCompletedFemoral Neck Fractures | Intertrochanteric FractureSweden, Denmark, Canada